The reagent kit for determining anti-Xa activity of heparin by coagulological method ("Reaklot-heparin") according to TU 9398-024-05595541-2011 is intended for monitoring heparin therapy by measuring the anti-Xa activity of heparin (both unfractionated and low molecular weight) in human plasma.
GP-1 Reagent kit for the determination of heparin anti-Xa activity by optical method with chromogenic substrate ("Reachrom-heparin") according to TU 9398-032-05595541-2011
GP-1/1 Reagent kit for determination of heparin antiXa activity by chromogenic method
"Renaparin-Plasma-Test" is a set of reagents designed for quantitative determination of anti-Xa and anti-IIa activities of low molecular weight heparin (LMWH) in blood plasma using chromogenic substrates. This method is intended solely for scientific research purposes.
Method Principle: The method for determining LMWH activity is based on the ability of the antithrombin III-heparin complex (AT III-LMWH) to neutralize activated factors Xa and IIa.
RENAPARIN-test (pharmaceutical preparations control)
A set of reagents for determining the activity of low-molecular-weight heparin.
Reagent set for determining the concentration of direct thrombin inhibitors using the clotting method*
* for scientific research only
Reagent set for determining the concentration of direct Factor Xa inhibitors*
* for scientific research only
Standard plasma (standard sample solution)*
R-211
Standard plasma without NOAC 1 ml
Standard plasma (standard sample solution)*
R-212
Standard plasma with rivaroxaban 1 ml
Control plasma*
R-213
Control plasma with rivaroxaban, level 2, 1 ml/vial 2 vials
Standard plasma (standard sample solution)*
R-214
Standard plasma with apixaban 1 ml
Control plasma*
R-215
Control plasma with apixaban, level 2, 1 ml/vial 2 vials
Buffer (concentrated)*
R-47
Buffer solution concentrated (Renaparin) 5 ml/vial 1 vial
* for scientific research only
